The Lymphoma Channel on VJHemOnc is an independent medical education platform, supported with funding from AstraZeneca (Diamond), BMS (Gold), Johnson & Johnson (Gold), Takeda (Silver) and Galapagos (Bronze). Supporters have no influence on the production of content. The levels of sponsorship listed are reflective of the amount of funding given.
EHA 2025 | Looking to the future of B-cell lymphoma treatment
In this video, Christian Buske, MD, University Hospital Ulm, Ulm, Germany, comments on the potential future of B-cell lymphoma treatment, predicting that chemotherapy-free approaches will dominate the landscape in years to come. He highlights the potential of targeted treatments, such as CAR T-cell therapies and bispecific antibodies, to revolutionize the treatment of various B-cell malignancies. This interview took place at the 30th Congress of the European Hematology Association (EHA) in Milan, Italy.
These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.
Transcript
Yeah, I think the same as the topic we had in the OLYMP-1 trial. So I think the world moves to chemotherapy-free approaches. And we see also here at EHA, but also beyond this meeting, that targeted treatments – bispecific antibodies, CAR-T’s – that these treatments have the potential really to revolutionize the treatment landscape in many B-cell malignancies...
Yeah, I think the same as the topic we had in the OLYMP-1 trial. So I think the world moves to chemotherapy-free approaches. And we see also here at EHA, but also beyond this meeting, that targeted treatments – bispecific antibodies, CAR-T’s – that these treatments have the potential really to revolutionize the treatment landscape in many B-cell malignancies. My guess is that these kind of chemo-free targeted approaches, they will be not only dominating, but they will actually, I think, lead to a chemo-free world in, I think, already five years in my mind.
This transcript is AI-generated. While we strive for accuracy, please verify this copy with the video.
Read more...
